Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart

Cardiovascular Drugs and Therapy
J ImagawaN Taira

Abstract

The coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, were evaluated in isolated, blood-perfused sinoatrial (SA) node, atrioventricular (AV) node, and papillary muscle preparations of dogs. NKY-722 was administered intraarterially. NKY-722 increased coronary blood flow in all preparations. In SA node preparations, NKY-722 reduced sinus rate and produced atrial standstill in large doses. The dose that produced a 15% (nearly half-maximum) decrease in sinus rate was about six times the dose that doubled coronary blood flow. In AV node preparations, NKY-722 prolonged AV conduction time and produced second- or third-degree AV block in large doses only when administered into the artery supplying the AV node. The dose that produced a 15% (nearly half-maximum) increase in AV conduction time was about 3.5 times the dose that doubled coronary blood flow. In paced papillary muscle preparations, NKY-722 reduced the force of contraction. However, the dose that produced a 50% decrease in the force of contraction of the paced papillary muscle was about 100 times the dose that doubled coronary blood flow. In spontaneously beating papillary muscle preparations, NKY-722 failed to change the ...Continue Reading

References

Feb 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·Y WadaN Taira
Jan 30, 1987·The American Journal of Cardiology·N Taira
May 1, 1970·The American Journal of Physiology·M Endoh, K Hashimoto
Jul 1, 1972·The Tohoku Journal of Experimental Medicine·K HashimotoN Taira
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R J GouldS H Snyder
Jun 1, 1982·Pflügers Archiv : European journal of physiology·J HeschelerW Trautwein
Oct 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·D R Ferry, H Glossmann
Apr 1, 1984·Journal of Pharmaceutical Sciences·J HasegawaJ Watanabe
Jan 22, 1982·European Journal of Pharmacology·K M Murphy, S H Snyder
Feb 11, 1982·Biochemical and Biophysical Research Communications·F J EhlertH I Yamamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.